(AGS) ageas SA/NV - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974264930
AGS: Life Insurance, Non-Life Insurance, Reinsurance, Pension Products
Ageas SA/NV (BR:AGS) stands as a testament to resilience and adaptability in the insurance sector, with a history dating back to 1824. This storied past underscores a legacy of trust and stability, attributes that are paramount for investors seeking dependable investments. The companys strategic diversification across Belgium, Europe, Asia, and beyond, including a robust reinsurance arm, exemplifies a prudent approach to risk mitigation, crucial for navigating the volatile global market landscape.
Operational excellence is evident in Ageass multi-line insurance offerings, encompassing life, casualty, and pension products, alongside a comprehensive suite of non-life insurance solutions. This diversified product range not only broadens market reach but also enhances revenue streams, providing a buffer against sector-specific downturns. Their distribution network, leveraging both brokers and banks, ensures a wide market penetration, serving individuals and corporations alike, thus underpinning consistent growth prospects.
From a financial standpoint, Ageas presents an intriguing profile with a market capitalization of 9.06 billion EUR, signaling a substantial market presence. The price-to-earnings ratio of 8.60, coupled with a forward P/E of 5.85, suggests undervaluation relative to industry peers, offering a potential upside for discerning investors. The price-to-book ratio of 1.20 indicates moderate valuation, while the price-to-sales ratio of 1.12 reflects efficient revenue generation, aligning with prudent investment criteria.
In conclusion, Ageas SA/NV emerges as a compelling investment opportunity, blending historical stability with strategic diversification and a favorable financial outlook. For investors and fund managers, Ageas represents a balanced blend of risk management and growth potential, supported by a robust operational framework and a strong financial position.
Additional Sources for AGS Stock
AGS Stock Overview
Market Cap in USD | 10,629m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
AGS Stock Ratings
Growth Rating | 83.1 |
Fundamental | 17.7 |
Dividend Rating | 68.9 |
Rel. Strength | 10.8 |
Analysts | - |
Fair Price Momentum | 62.48 EUR |
Fair Price DCF | 68.31 EUR |
AGS Dividends
Dividend Yield 12m | 10.49% |
Yield on Cost 5y | 24.17% |
Annual Growth 5y | 4.17% |
Payout Consistency | 84.6% |
AGS Growth Ratios
Growth Correlation 3m | 65.8% |
Growth Correlation 12m | 92.3% |
Growth Correlation 5y | 72.9% |
CAGR 5y | 19.34% |
CAGR/Max DD 5y | 0.76 |
Sharpe Ratio 12m | 2.05 |
Alpha | 27.90 |
Beta | 0.378 |
Volatility | 39.26% |
Current Volume | 524.5k |
Average Volume 20d | 494.4k |
As of April 25, 2025, the stock is trading at EUR 53.55 with a total of 524,475 shares traded.
Over the past week, the price has changed by +0.47%, over one month by -4.29%, over three months by +9.20% and over the past year by +30.52%.
Neither. Based on ValueRay Fundamental Analyses, ageas SA/NV is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.68 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AGS as of April 2025 is 62.48. This means that AGS is currently undervalued and has a potential upside of +16.68% (Margin of Safety).
ageas SA/NV has no consensus analysts rating.
According to ValueRays Forecast Model, AGS ageas SA/NV will be worth about 68.2 in April 2026. The stock is currently trading at 53.55. This means that the stock has a potential upside of +27.32%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 55.9 | 4.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 68.2 | 27.3% |